New transplant method aims to cure rare immune disease
NCT ID NCT02629120
Summary
This study is testing a modified stem cell transplant procedure for people with chronic granulomatous disease (CGD), a rare genetic disorder that weakens the immune system. Researchers are using a high dose of donor stem cells along with specific medications after the transplant to help the body accept the new cells while reducing dangerous side effects. The goal is to replace the faulty immune system with a healthy one, potentially providing long-term control of the disease for participants aged 4 to 65.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRANULOMATOUS DISEASE TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.